Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

The KRTAP22-2 gene in sheep does not significantly affect wool traits.

FERONIA is crucial for plant growth, pollen tube reception, and sugar signaling.

A genetic marker linked to a type of hair loss was found in most patients studied.

Icariside II may help treat gastric cancer by stopping tumor growth.

iL-PRF treatment improves hair growth for androgenetic alopecia.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Actin filaments help stabilize and integrate cell membranes during transfer.

Ishophloroglucin A from Ishige okamurae may be a natural alternative for treating hair loss by inhibiting 5α-reductase and promoting hair growth.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

A specific RNA helps increase the growth of skin cells in Liaoning cashmere goats by working with a protein to boost a growth-related gene.

Infrared light can trigger drug release from gold nanoparticle carriers in hair follicles.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Glutathione helps Arabidopsis roots adapt to low phosphate by regulating a specific growth pathway.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.